🔖
Cite This Article
ERTUĞRUL, S., SELÇUK, F. (2022). Levetiracetam Responsive in Late-Onset Idiopathic Paroxysmal Kinesigenic Dyskinesia. Cyprus Journal of Medical Sciences, Cilt: 6 - Sayı: 1, 105–106. https://ajindex.com/articles/649493
Journals / Cyprus Journal of Medical Sciences / 2021 / Cilt: 6 - Sayı: 1
Levetiracetam Responsive in Late-Onset Idiopathic Paroxysmal Kinesigenic Dyskinesia
- Pages
- 105–106
- Publication Date
- 2022-11-06
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (1)
- Wei Sun, Jianing Li, Yulan Zhu, Xiaobo Yan, Weizhi Wang. Clinical features of paroxysmal kinesigenic dyskinesia: Report of 24 cases. Epilepsy Behav 2012; 25(4): 695-9. [Crossref] 2. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38(4): 571-9. [Crossref] 3. Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43(12): 1252-5. [Crossref] 4. Bruno MK, Hallett M, Gwinn-Hardy K, Sorensen B, Considine E, Tucker S, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: New diagnostic criteria. Neurology 2004; 63(12): 2280-7. [Crossref] 5. Chillag KL, Deroos ST. Oxcarbazepine use in paroxysmal kinesigenic dyskinesia: report on four patients. Pediatr Neurol 2009; 40(4): 295-7. [Crossref]